gout

Savient's Krystexxa: How I Get A $209 Million Sales Estimate By 2015
Seeking Alpha
Thu, 12/8/11 - 11:33 am
Savient
gout
Krystexxa
Savient Pharmaceuticals: The Potential Role Of Krystexxa The Treatment Of Gout
Seeking Alpha
Sat, 12/3/11 - 11:06 am
Savi
Krystexxa
gout
Savient Pharmaceuticals: Sluggish Launch Of Krystexxa Presents Buying Opportunity
Seeking Alpha
Wed, 11/30/11 - 05:29 pm
Krystexxa
Savient
gout
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Yahoo/AP
Fri, 11/11/11 - 09:50 am
Savient
gout
Krystexxa
Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
Yahoo/PR NewsWire
Sat, 11/5/11 - 02:49 pm
Savient
Krystexxa
gout
New Medicare code could boost Krystexxa sales
Fierce Pharma
Fri, 11/4/11 - 12:19 pm
Medicare
Krystexxa
gout
Savient
Gout drug developer Ardea reports bigger 3Q loss
Yahoo/AP
Fri, 11/4/11 - 12:17 pm
Ardea
earnings
gout
BioCryst says gout drug worked in mid-stage trial
Yahoo/AP
Wed, 10/5/11 - 10:54 am
Biocryst
gout
BCX4208
Ardea Agrees with FDA on Gout Candidate
Yahoo/Zacks
Sat, 09/10/11 - 09:58 am
RDEA594
lesinurad
gout
Ardea
Ardea agrees with FDA on gout drug studies
Yahoo/AP
Thu, 09/8/11 - 11:16 am
FDA
Ardea
gout
lesinurad
FDA asks Novartis for more data on gout drug
Reuters
Mon, 08/29/11 - 01:11 pm
gout
FDA
Novartis
Ilaris
FDA votes against Novartis gout drug: WSJ
Marketwatch
Wed, 06/22/11 - 09:03 am
FDA
advisory panels
Novartis
gout
Ilaris
US FDA staff-Novartis gout drug data 'complicated'
Reuters
Fri, 06/17/11 - 12:22 pm
FDA
Novartis
gout
Ilaris
Ardea shares climb after release of study results
Yahoo/AP
Fri, 05/27/11 - 08:54 am
lesinurad
Ardea
gout
A.M. Vitals: Novartis Says Experimental Gout Drug is Effective
Wed, 05/25/11 - 10:04 pm
Novartis
gout
Ardea Biosciences Evenly Poised
Yahoo/Zacks.com
Wed, 05/25/11 - 09:50 am
Ardea
HIV
cancer
gout
Novartis Says Experimental Gout Drug is Effective
WSJ Online
Wed, 05/25/11 - 09:21 am
gout
Novartis
Ilaris
Savient Pharma: Cheap Biotech Without FDA Approval Risk
Seeking Alpha
Tue, 04/26/11 - 06:18 am
Savient
gout
Krystexxa
BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology
Yahoo/BusinessWire
Sat, 04/23/11 - 10:46 am
gout
Biocryst
BCX4208
purine nucleoside phosphorylase inhibitor
Gout medicine Colcrys' pricing under scrutiny
Fierce Pharma
Tue, 03/29/11 - 11:44 am
Colcrys
gout
drug pricing
URL Pharma

Pages